Winway Health Desk
Teva extends global rebrand with tailored marketing messages for caregivers
Teva research found that 36% of Canadians self-identify as caregivers. So when the Israeli drugmaker rolled out its global rebrand in Canada, it decided...
JPM: Alnylam CEO looks to action-packed 2020 on the heels of...
Still basking in an FDA approval for its second RNAi therapy, Alnylam is thinking big about just how far it can go with its new and impending...
JPM: Already prepping for Alzheimer’s launch, Biogen scouts ‘top talent’ and...
Biogen hasn't even filed its FDA application for controversial Alzheimer's drug aducanumab yet. But it's already started gearing up for a potential launch.
After a...
SLAM Launches New Brand Platform
The S/L/A/M Collaborative (SLAM), a design firm offering architectural, structural engineering, and construction services with offices in Connecticut, California, Georgia, Massachusetts and New York,...
AbbVie’s new hope Skyrizi bests Novartis’ Cosentyx at clearing patients’ skin
AbbVie is placing high hopes in its next-gen psoriasis med Skyrizi as it looks for business drivers in the post-Humira, post-Allergan merger landscape. With...
Research hospital jumping into commercial production of gene therapies
A new commercial-scale gene therapy manufacturing facility is being planned, but not by a biotech or even a CDMO. This one will be built...
JPM: Watch out, Roche. BioMarin’s gene therapy might bleed off the...
SAN FRANCISCO—Roche bought Spark Therapeutics in 2019 mainly for its hemophilia gene therapy projects to complement FDA-approved antibody drug Hemlibra. But thanks to a...
Finding the Corpus of Knowledge for Machine Learning/AI In Chemistry
Posted on January 14th, 2020 by Matthew Clark in Chemistry...
The one regret of Omar Ishrak, Medtronic’s retiring CEO
Medtronic CEO Omar Ishrak in his office in Minnesota in 2011
Medtronic’s retiring Chairman & CEO, Omar Ishrak, who has led the world’s largest pure-play...
Hospitals sue CMS again over site-neutral payments
Hospitals once again sued the Centers for Medicare and Medicaid Services over its site-neutral payment policy. The final rule reduced Medicare reimbursement rates for...